Related references
Note: Only part of the references are listed.Noncoding Mutations of HGF Are Associated with Nonsyndromic Hearing Loss, DFNB39
Julie M. Schultz et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Efficacy of Systemic Morpholino Exon-Skipping in Duchenne Dystrophy Dogs
Toshifumi Yokota et al.
ANNALS OF NEUROLOGY (2009)
A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice
Masayuki Sekiguchi et al.
BRAIN (2009)
Rethinking ALS: The FUS about TDP-43
Clotilde Lagier-Tourenne et al.
CELL (2009)
Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation
Kathrin Meyer et al.
HUMAN MOLECULAR GENETICS (2009)
A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice
HaiFang Yin et al.
HUMAN MOLECULAR GENETICS (2009)
Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy
Travis D. Baughan et al.
HUMAN MOLECULAR GENETICS (2009)
Theoretic Applicability of Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy Mutations
Annemieke Aartsma-Rus et al.
HUMAN MUTATION (2009)
Mechanisms of RNA-mediated Disease
Jason R. O'Rourke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy
Hitoko Ogata et al.
JOURNAL OF CARDIOLOGY (2009)
In vivo comparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
Hans A. Heemskerk et al.
JOURNAL OF GENE MEDICINE (2009)
Oligonucleotide-Mediated Survival of Motor Neuron Protein Expression in CNS Improves Phenotype in a Mouse Model of Spinal Muscular Atrophy
Jason H. Williams et al.
JOURNAL OF NEUROSCIENCE (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. (vol 8, pg 918, 2009)
M. Kinali et al.
LANCET NEUROLOGY (2009)
Guidelines for Antisense Oligonucleotide Design and Insight Into Splice-modulating Mechanisms
Annemieke Aartsma-Rus et al.
MOLECULAR THERAPY (2009)
Octa-guanidine Morpholino Restores Dystrophin Expression in Cardiac and Skeletal Muscles and Ameliorates Pathology in Dystrophic mdx Mice
Bo Wu et al.
MOLECULAR THERAPY (2009)
Cationic PMMA Nanoparticles Bind and Deliver Antisense Oligoribonucleotides Allowing Restoration of Dystrophin Expression in the mdx Mouse
Paola Rimessi et al.
MOLECULAR THERAPY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Arthur H. M. Burghes et al.
NATURE REVIEWS NEUROSCIENCE (2009)
Cardiogenetics, Neurogenetics, and Pathogenetics of Left Ventricular Hypertrabeculation/Noncompaction
Josef Finsterer
PEDIATRIC CARDIOLOGY (2009)
Pentamidine reverses the splicing defects associated with myotonic dystrophy
M. Bryan Warf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy
Susan A. M. Mulders et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity
Yong-Jie Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy
Natalia N. Singh et al.
RNA BIOLOGY (2009)
Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA
Thurman M. Wheeler et al.
SCIENCE (2009)
RNA Gain-of-Function in Spinocerebellar Ataxia Type 8
Randy S. Daughters et al.
PLOS GENETICS (2009)
Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides
Shashank R Sirsi et al.
JOURNAL OF NANOBIOTECHNOLOGY (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
Maria Kinali et al.
LANCET NEUROLOGY (2009)
Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in Transgenic mice
Yimin Hua et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Assessment of the feasibility of exon 45-55 multiexon skipping for duchenne muscular dystrophy
Laura van Vliet et al.
BMC MEDICAL GENETICS (2008)
Is good housekeeping the key to motor neuron survival?
Kevin Talbot et al.
CELL (2008)
SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing
Zhenxi Zhang et al.
CELL (2008)
A Negatively Acting Bifunctional RNA Increases Survival Motor Neuron Both In Vitro and In Vivo
Alexa Dickson et al.
HUMAN GENE THERAPY (2008)
Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function
HaiFang Yin et al.
HUMAN MOLECULAR GENETICS (2008)
Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus
David A. Stein et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice
Haifang Yin et al.
MOLECULAR THERAPY (2008)
Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle
DeWayne Townsend et al.
MOLECULAR THERAPY (2008)
Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice
Natee Jearawiriyapaisarn et al.
MOLECULAR THERAPY (2008)
HITS-CLIP yields genome-wide insights into brain alternative RNA processing
Donny D. Licatalosi et al.
NATURE (2008)
Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy
Larry W. Markham et al.
NEUROMUSCULAR DISORDERS (2008)
Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle
Gabriela D. Ivanova et al.
NUCLEIC ACIDS RESEARCH (2008)
Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer
Bo Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Combinatorial control of exon recognition
Klemens J. Hertel
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Local dystrophin restoration with antisense oligonucleotide PRO051
Judith C. van Deutekom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Increased steady-state in levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation
N. Muge Kuyumcu-Martinez et al.
MOLECULAR CELL (2007)
Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications
Annemieke Aartsma-Rus et al.
RNA (2007)
Morpholino oligomer -: Mediated Exon skipping averts the onset of dystrophic pathology in the mdx mouse
Sue Fletcher et al.
MOLECULAR THERAPY (2007)
Spinal muscular atrophy:: SMN2 pre-mRNA splicing corrected by a U7 snRNA derivative carrying a splicing enhancer sequence
Julien Marquis et al.
MOLECULAR THERAPY (2007)
Restoration of SMN function:: Delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing
Tristan H. Coady et al.
MOLECULAR THERAPY (2007)
Cell-penetrating-peptide-based delivery of oligonucleotides: an overview
R. Abes et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript
Steve D. Wilton et al.
MOLECULAR THERAPY (2007)
Red-green color vision impairment in Duchenne muscular dystrophy
Marcelo Fernandes Costa et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Enhancement of SMN2 Exon 7 inclusion by antisense oligonucleotides targeting the exon
Yimin Hua et al.
PLOS BIOLOGY (2007)
RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events
Emanuele Buratti et al.
NUCLEIC ACIDS RESEARCH (2007)
Comparative analysis of antisense oligonucleotide sequences for targeted skipping of Exon 51 during dystrophin Pre-mRNA splicing in human muscle
V. Arechavala-Gomeza et al.
HUMAN GENE THERAPY (2007)
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
G. McClorey et al.
GENE THERAPY (2006)
Molecular mechanisms of muscular dystrophies: old and new players
Kay E. Davies et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy
Mani S. Mahadevan et al.
NATURE GENETICS (2006)
Exploring the frontiers of therapeutic dxon skipping for Duchenne muscular dystrophy by double targeting within one or multiple dxons
Annemieke Aartsma-Rus et al.
MOLECULAR THERAPY (2006)
Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule
Annemieke Aartsma-Rus et al.
MUSCLE & NERVE (2006)
Alternative splicing: New insights from global analyses
Benjamin J. Blencowe
CELL (2006)
Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8
Melinda L. Moseley et al.
NATURE GENETICS (2006)
Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy
Xiaoyan Lin et al.
HUMAN MOLECULAR GENETICS (2006)
DM2 intronic expansions:: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression
Jamie M. Margolis et al.
HUMAN MOLECULAR GENETICS (2006)
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model
MA Denti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
J Alter et al.
NATURE MEDICINE (2006)
Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucteotide
S Fletcher et al.
JOURNAL OF GENE MEDICINE (2006)
The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C
S Kishore et al.
SCIENCE (2006)
Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2
L Cartegni et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Correction of SMN2 pre-mRNA splicing by antisense U7 small nuclear RNAs
C Madocsai et al.
MOLECULAR THERAPY (2005)
Dystrophic heart failure blocked by membrane sealant poloxamer
S Yasuda et al.
NATURE (2005)
Arginine-rich peptide conjugation to morpholino oligomers: Effects on antisense activity and specificity
MH Nelson et al.
BIOCONJUGATE CHEMISTRY (2005)
Understanding alternative splicing: Towards a cellular code
AJ Matlin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles
QL Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Targeted exon skipping in transgenic hDMD mice:: A model for direct preclinical screening of human-specific antisense oligonucleotides
M Bremmer-Bout et al.
MOLECULAR THERAPY (2004)
Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping
A Goyenvalle et al.
SCIENCE (2004)
Advances in Duchenne muscular dystrophy gene therapy
JCT van Deutekom et al.
NATURE REVIEWS GENETICS (2003)
Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse
QL Lu et al.
NATURE MEDICINE (2003)
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
T Kashima et al.
NATURE GENETICS (2003)
Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle
BL Gebski et al.
HUMAN MOLECULAR GENETICS (2003)
Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients
A Aartsma-Rus et al.
HUMAN MOLECULAR GENETICS (2003)
Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts
LA Skordis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Correction of disease-associated exon skipping by synthetic exon-specific activators
L Cartegni et al.
NATURE STRUCTURAL BIOLOGY (2003)
Dystrophin and mutations: one gene, several proteins, multiple phenotypes
F Muntoni et al.
LANCET NEUROLOGY (2003)
The heart in human dystrophinopathies
J Finsterer et al.
CARDIOLOGY (2003)
Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Δ48-50 DMD cells
FG De Angelis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A new type of mutation causes a splicing defect in ATM
F Pagani et al.
NATURE GENETICS (2002)
Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3′ splice site pairing
SR Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA
ML Zhang et al.
GENE THERAPY (2001)
Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells
JCT van Deutekom et al.
HUMAN MOLECULAR GENETICS (2001)
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse
CJ Mann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin
IN Rybakova et al.
JOURNAL OF CELL BIOLOGY (2000)
Distinct patterns of dystrophin organization in myocyte sarcolemma and transverse tubules of normal and diseased human myocardium
RR Kaprielian et al.
CIRCULATION (2000)
Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion
QL Lu et al.
JOURNAL OF CELL BIOLOGY (2000)
Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
E Ars et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
